Next Article in Journal
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection
Previous Article in Journal
Lessons from the COVID-19 Pandemic: Promoting Vaccination and Public Health Resilience, a Narrative Review
 
 
Article

Article Versions Notes

Vaccines 2024, 12(8), 892; https://doi.org/10.3390/vaccines12080892
Action Date Notes Link
article xml file uploaded 7 August 2024 11:47 CEST Original file -
article xml uploaded. 7 August 2024 11:47 CEST Update -
article pdf uploaded. 7 August 2024 11:47 CEST Version of Record https://www.mdpi.com/2076-393X/12/8/892/pdf-vor
article supplementary file uploaded. 7 August 2024 11:47 CEST - https://www.mdpi.com/2076-393X/12/8/892#supplementary
article html file updated 7 August 2024 11:48 CEST Original file -
article xml file uploaded 8 August 2024 06:22 CEST Update -
article xml uploaded. 8 August 2024 06:22 CEST Update https://www.mdpi.com/2076-393X/12/8/892/xml
article pdf uploaded. 8 August 2024 06:22 CEST Updated version of record https://www.mdpi.com/2076-393X/12/8/892/pdf
article html file updated 8 August 2024 06:25 CEST Update https://www.mdpi.com/2076-393X/12/8/892/html
Back to TopTop